risks of compounded tirzepatide With B6 (Pyridoxine) Protect access to compounded GLP-1

Common GI effects at 7.5 mg include: Mild nausea, especially in the first 48 hours after injection Reduced bowel movement frequency Occasional bloating after larger meals Decreased tolerance for fatty or heavy foods If you experienced significant anxiety or mood effects at lower doses, monitor these at 7.5 mg as well

Enhanced Fat Oxidation and Body Composition Improvement: The primary benefit documented in research is the enhancement of fat metabolism and reduction in body weight gain

Also, be sure to read the label thoroughly, as some products may contain additional ingredients that could be contraindicated for certain populations

For a short-term buyer, the risk is that part of the Retatrutide success story is already being priced in, and further gains may come with pullbacks along the way